A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India

Autor:	Vinayak Nikam, Kota Venugopal, Ravi Mohanka, Selvakumar Malleeswaran, Prashantha S Rao, Ellango Appusamy, Chandhan Kumar Kedarisetty, Raghavendra Babu Yalakanti, Bhaskaran Pillai Venugopal, Sunil D. Shenvi, Perumal Karnan, Anurag Shrimal, Nigel Heaton, Joy Varghese, Dharmesh Kapoor, Rajanikanth V. Patcha, Karan Kumar, Balbir Singh
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	2019-20 coronavirus outbreak Transplantation Coronavirus disease 2019 (COVID-19) Hepatology business.industry medicine.medical_treatment Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030230 surgery Liver transplantation Chronic liver disease medicine.disease Virology 03 medical and health sciences 0302 clinical medicine medicine 030211 gastroenterology & hepatology New delhi Surgery Living donor liver transplantation business
Zdroj:	Liver Transplantation
ISSN:	1527-6473 1527-6465
DOI:	10.1002/lt.25957
Popis:	As of August 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 213 countries, leading to more than 18 million cases and 690,000 deaths. India is the second most affected country, with the majority of cases in metropolitan cities, such as Mumbai, New Delhi, Chennai, and Bengaluru. There is limited literature on the outcomes and safety of performing living donor liver transplantation (LDLT) in coronavirus disease 2019 (COVID-19) epicenters.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09dce9e535fcb1371241cfcb211bf542 Zobrazit plný text záznamu Plný text